Human induced pluripotent stem cell-based platform for modeling cardiac ischemia

• Published in: Scientific reports 2021-02, Vol.11 (1), p.4153-4153, Article 4153
• Main Authors: Häkli, Martta, Kreutzer, Joose, Mäki, Antti-Juhana, Välimäki, Hannu, Lappi, Henna, Huhtala, Heini, Kallio, Pasi, Aalto-Setälä, Katriina, Pekkanen-Mattila, Mari
• Format: Article
• Language: English
• Subjects: 631/1647/767/1657; 631/532/2064/2158; Animal models; Cardiomyocytes; Cardiovascular diseases; Cell Line; Coronary artery disease; Depolarization; Glucose transporter; Heart diseases; Humanities and Social Sciences; Humans; Hypoxia; Induced Pluripotent Stem Cells - cytology; Ischemia; multidisciplinary; Myocardial Ischemia - therapy; Myocytes, Cardiac - cytology; Oxygen; Phenotype; Phenotypes; Pluripotency; Reperfusion; Sarcomeres - pathology; Science; Science (multidisciplinary); Stem cells
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-021-83740-w

Ischemic heart disease is a major cause of death worldwide, and the only available therapy to salvage the tissue is reperfusion, which can initially cause further damage. Many therapeutics that have been promising in animal models have failed in human trials. Thus, functional human based cardiac ischemia models are required. In this study, a human induced pluripotent stem cell derived-cardiomyocyte (hiPSC-CM)-based platform for modeling ischemia–reperfusion was developed utilizing a system enabling precise control over oxygen concentration and real-time monitoring of the oxygen dynamics as well as iPS-CM functionality. In addition, morphology and expression of hypoxia-related genes and proteins were evaluated as hiPSC-CM response to 8 or 24 h hypoxia and 24 h reoxygenation. During hypoxia, initial decrease in hiPSC-CM beating frequency was observed, after which the CMs adapted to the conditions and the beating frequency gradually increased already before reoxygenation. During reoxygenation, the beating frequency typically first surpassed the baseline before settling down to the values close the baseline. Furthermore, slowing on the field potential propagation throughout the hiPSC-CM sheet as well as increase in depolarization time and decrease in overall field potential duration were observed during hypoxia. These changes were reversed during reoxygenation. Disorganization of sarcomere structures was observed after hypoxia and reoxygenation, supported by decrease in the expression of sarcomeric proteins. Furthermore, increase in the expression of gene encoding glucose transporter 1 was observed. These findings indicate, that despite their immature phenotype, hiPSC-CMs can be utilized in modeling ischemia–reperfusion injury.